Alessandra Romano, MD, PhD, University of Catania, Catania, Italy, briefly comments on the use of daratumumab in combination with bortezomib, cyclophosphamide and dexamethasone (Dara-VCd) to treat patients with amyloidosis. This interview took place at the 4th Society of Hematologic Oncology (SOHO) Italy Annual Conference, held in Rome, Italy.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.